George A. Karpouzas, MD

Harbor-UCLA Medical Center
Torrance, CA, United States

Professor of Medicine, David Geffen School of Medicine, UCLA
Chief, Division of Rheumatology, Harbor-UCLA Medical Center
The Lundquist Institute for Medical Innovation

Disclosure information not submitted.

Presentation(s):

• 1401: Relationship Between Disease Activity and Adverse Events of Interest in Patients with RA on Tofacitinib or TNF Inhibitors: Post Hoc Analysis of a Phase 3b/4 Randomized Safety Study

  Saturday, November 12, 2022
  1:40 PM – 1:45 PM Eastern Time

• 0883: Serum Cholesterol Loading Capacity on Macrophages Is Dependent on Oxidized Low-density Lipoprotein and Regulated by Seropositivity and C-reactive Protein in Patients with Rheumatoid Arthritis

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 0893: ATP-Binding Cassette G1 Membrane Transporter-mediated Cholesterol Efflux Capacity Influences Coronary Atherosclerosis and Cardiovascular Risk in RA

  Sunday, November 13, 2022
  9:00 AM – 10:30 AM Eastern Time

• 1401: Relationship Between Disease Activity and Adverse Events of Interest in Patients with RA on Tofacitinib or TNF Inhibitors: Post Hoc Analysis of a Phase 3b/4 Randomized Safety Study

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time